CommercialPrior AuthMedium impact
Pharmacy Medical Policy Updates
Blue Cross Blue Shield of Kansas·KS · Rheumatology, Endocrinology, Neurology +4 more·Pharmacy
Effective date
Mar 1, 2025
We identified it
Jun 19, 2026
Summary
BCBSKS is updating pharmacy medical policies for multiple drug categories including biologics, weight management drugs, and specialty medications effective March 1, 2025. These updates will affect prior authorization requirements and coverage criteria for medications administered in healthcare settings and through pharmacy benefits.
Action Required
Before March 1, 2025: Billing team must review updated pharmacy medical policies on the BCBSKS website at https://www.bcbsks.com/providers/precertification-prior-authorization for all affected drug categories (Biologic Immunomodulators, Cibinqo, HCPA Biologics, IL-4/IL-5/IL-13 inhibitors, Multiple Sclerosis drugs, Nasal Inhalers, Niemann-Pick Type C Agents, Sohonosm Tezspire, Tryvio, Weight Management drugs, Xolair, Yorvipath, Zeposia). Update prior authorization workflows and notify providers of any new requirements. Contact BCBSKS provider representative for clarification on specific policy changes.